Vitamin D: who should test, who should supplement, and who can wait

Vitamin D spent a decade as a candidate explanation for almost every modern disease. Low blood levels showed up next to depression, infections, heart attacks, and poor COVID outcomes. The pattern is a classic epidemiology trap: people who are ill, older, heavier, or less able to go outside have lower 25-hydroxyvitamin D. That does not prove that a capsule would have prevented the illness.

Large supplementation trials in adults who were not frankly deficient have been sobering. Cancer and cardiovascular prevention did not arrive on schedule. Fracture benefits in already-sufficient, community-dwelling adults have been small or absent. That is not an argument for ignoring deficiency. It is an argument for putting vitamin D back in its actual job description.

What vitamin D does that we are sure about

Skin makes vitamin D when UVB light hits 7-dehydrocholesterol. The liver and kidney then convert it to the hormone that helps the gut absorb calcium. Without enough of that system, from diet, sun, or supplements, calcium handling suffers. Severe, prolonged deficiency causes rickets in children and osteomalacia in adults. That pathology is not a wellness metaphor.

Food sources are limited: fatty fish, egg yolks, UV-exposed mushrooms, and fortified milk or plant milks. Most people at higher latitudes, or who spend their days indoors, will not reliably hit even the RDA from unfortified food alone in winter. That is the boring case for a modest daily supplement for many adults, especially in the northern United States.

Blood tests: use them when they change a plan

25-hydroxyvitamin D is the circulating marker laboratories report. Laboratories and guidelines disagree about where “sufficient” begins. Common clinical practice treats values below about 12 ng/mL (30 nmol/L) as deficient and values in a middle band as a judgment call. Some specialty guidelines have used higher targets; those targets have been criticized as medicalizing a normal seasonal dip.

We do not recommend annual testing for healthy adults with no risk factors and no plan to act on a middle-range result. Screening recommendations from prevention task forces have been cautious for that reason.

Testing is more defensible when:

• You have osteoporosis, osteomalacia, or a malabsorption condition (celiac disease, inflammatory bowel disease, bypass surgery).
• You have limited sun exposure for cultural, occupational, or medical reasons, or you live at a high latitude and rarely see midday sun.
• You have darker skin and spend little time outdoors in a climate with a real winter.
• You are older, institutionalized, or on medications that interfere with vitamin D metabolism (certain anticonvulsants, for example).
• A clinician is investigating unexplained hypocalcemia or bone pain.

If you supplement, retesting too early is a waste. 25(OH)D changes over weeks, not days. Follow the interval your clinician set.

Dose: enough is not the same as more

The official U.S. recommended intakes for most adults are 600 IU (15 mcg) daily, and 800 IU (20 mcg) for people 71 and older. The tolerable upper intake level for adults is typically cited at 4,000 IU (100 mcg) from all sources, not as a target.

Many over-the-counter bottles contain 2,000 or 5,000 IU. For someone who is deficient under medical care, a time-limited higher dose can be appropriate. As a standing daily habit for a person who already spends time outside in summer, 5,000 IU is often surplus. Very high intermittent megadoses have been associated with falls or fractures in some older-adult trials, a reminder that “more hormone” is not a one-way street.

Vitamin D3 (cholecalciferol) raises 25(OH)D somewhat more reliably than D2 (ergocalciferol) in head-to-head work. For a daily consumer product, D3 is the default we expect to prefer unless there is a dietary reason to choose D2. Calcium should be considered separately: stacking high-dose D with high-dose calcium is a different risk conversation, especially for people who already eat a lot of dairy.

Toxicity is uncommon and usually involves long-term high doses, not a week of forgetfulness. It presents as hypercalcemia, nausea, confusion, kidney stones, and is a reason we will flag products that encourage casual 10,000 IU use.

Extra-skeletal claims: keep the receipt

Observational links to immunity, mood, athletic performance, and metabolic disease were a reasonable basis for trials. The trials did not give the supplement industry the result it wanted. We will say so plainly. If a later, well-run study in a frankly deficient population shows a clear benefit for a specific outcome, we will update. We will not keep a claim alive because it is popular in podcasts.

Pregnancy, infants, and people with specific endocrine disorders are outside the scope of this general guide and belong with clinical care.

How this sets up our future rankings

Vitamin D is an obvious Best of category: the products are cheap, the labels vary, and the marketing often implies a broader benefit than bone and deficiency correction. A good ranking will ask whether the listed IU is accurate, whether the serving size quietly exceeds a safe daily habit, and whether the company pairs D with a spray of unnecessary extras.

Until then, a plain D3 supplement in the 600–2,000 IU range, taken daily if food and sun are unreliable, is a sufficient consumer stance for most healthy adults. Get a test when the result would change that stance, not to collect a number.

Do not start high-dose vitamin D, calcium, or combination bone products without checking interactions if you have kidney disease, granulomatous disease, or high blood calcium. This is not a dosing protocol.